Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Jennifer Munkley

Newcastle AuthorsTitleYearFull text
Kayla Bastian
Maggie Orozco Moreno
Huw Thomas
Dr Kirsty Hodgson
Laura Wilson
et al.		FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors2025
Chile Siachisumo
Dr Sara Luzzi
Saad Aldalaqan
Dr Gerald Hysenaj
Caroline Dalgliesh
et al.		An anciently diverged family of RNA binding proteins maintain correct splicing of a class of ultra-long exons through cryptic splice site repression2024
Dr Kirsty Hodgson
Maggie Orozco Moreno
Emily Archer Goode
Dr Rebecca Garnham
Karen Livermore
et al.		Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone2024
Maggie Orozco Moreno
Dr Kirsty Hodgson
Amirah Nabilah
Meera Murali
Jess Peng
et al.		Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells2024
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.		ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer2024
Rahul Advani
Dr Sara Luzzi
Dr Emma Scott
Caroline Dalgliesh
Dr Jennifer Munkley
et al.		Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer2023
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.		ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer2023
Dr Emma Scott
Emily Archer Goode
Rebecca Garnham
Dr Kirsty Hodgson
Maggie Orozco Moreno
et al.		ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression2023
Maggie Orozco Moreno
Dr Kirsty Hodgson
Kayla Bastian
Emily Archer Goode
Dr Jennifer Munkley
Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors2023
Dr Kirsty Hodgson
Maggie Orozco Moreno
Dr Emma Scott
Rebecca Garnham
Karen Livermore
et al.		The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer2023
Dr Emma Scott
Dr Kirsty Hodgson
Kat Cheung
Edward Yo
Laura Wilson
et al.		Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth2023
Dr Jennifer Munkley
Aberrant Sialylation in Cancer: Therapeutic Opportunities2022
Adam Duxfield
Dr Jennifer Munkley
Professor Michael Briggs
Dr Ella Dennis
CRELD2 is a novel modulator of calcium release and calcineurin-NFAT signalling during osteoclast differentiation2022
Dr Emma Scott
Rebecca Garnham
Adam Duxfield
Professor David Elliott
Dr Jennifer Munkley
Pro-Survival Factor EDEM3 Confers Therapy Resistance in Prostate Cancer2022
Kayla Bastian
Dr Emma Scott
Professor David Elliott
Dr Jennifer Munkley
Fut8 alpha-(1,6)-fucosyltransferase in cancer2021
123